Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration

Cancer metastasis accounts for most of the mortality associated with solid tumors. However, antimetastatic drugs are not available on the market. One of the important biological events leading to metastasis is the epithelial to mesenchymal transition (EMT) induced by cytokines, namely transforming g...

Descripción completa

Detalles Bibliográficos
Autores principales: Toma, Tsugumasa, Tateishi, Hiroshi, Kawakami, Kensaku, Ali, Taha F. S., Kamo, Masahiro, Monde, Kazuaki, Nakashima, Yuta, Fujita, Mikako, Otsuka, Masami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102712/
https://www.ncbi.nlm.nih.gov/pubmed/35563439
http://dx.doi.org/10.3390/ijms23095047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102712/
https://www.ncbi.nlm.nih.gov/pubmed/35563439
http://dx.doi.org/10.3390/ijms23095047

Ejemplares similares